Juan Luis Steegmann
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 63
- Acute Myeloid Leukemia Research 3
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 49
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 21
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- Acute Lymphoblastic Leukemia research 9
-
- Mast cells and histamine 3
- Co-authors
- Rüdiger HehlmannHanneke C. Kluin‐NelemansMarkus PfirrmannJoerg HasfordN. C. AllanG. AlimenaMichele BaccaraniHassan Ansari
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Juan Luis Steegmann
71 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 1.9k
- Genetics 1.6k
- Rheumatology 929
- Oncology 329
- Pathology and Forensic Medicine 200
Countries citing papers authored by Juan Luis Steegmann
This map shows the geographic impact of Juan Luis Steegmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Luis Steegmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Luis Steegmann more than expected).
Fields of papers citing papers by Juan Luis Steegmann
This network shows the impact of papers produced by Juan Luis Steegmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Luis Steegmann. The network helps show where Juan Luis Steegmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Juan Luis Steegmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2020 | 17 | |
| 3 | 2020 | 37 | |
| 4 | 2018 | 18 | |
| 5 | 2017 | 33 | |
| 6 | 2017 | 4 | |
| 7 | 2016 | 7 | |
| 8 | 2014 | 26 | |
| 9 | 2012 | 26 | |
| 10 | 2009 | 229 | |
| 11 | 2008 | 15 | |
| 12 | 2007 | 5 | |
| 13 | 2007 | 3 | |
| 14 | 2006 | 34 | |
| 15 | The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha. | 2005 | 10 |
| 16 | 2003 | 35 | |
| 17 | 2003 | 1 | |
| 18 | 2002 | 11 | |
| 19 | 1999 | 22 | |
| 20 | A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Groupbreakdown → | 1998 | 518 |
About Juan Luis Steegmann
Juan Luis Steegmann is a scholar working on Hematology, Genetics and Rheumatology, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (63 papers), Chronic Lymphocytic Leukemia Research (49 papers), Eosinophilic Disorders and Syndromes (21 papers), Acute Lymphoblastic Leukemia research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (3 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (1.6k citations) and Rheumatology (929 citations). Juan Luis Steegmann has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Rüdiger Hehlmann, Hanneke C. Kluin‐Nelemans, Markus Pfirrmann, Joerg Hasford, N. C. Allan, G. Alimena, Michele Baccarani, Hassan Ansari, Andreas Hochhaus and Giuseppe Saglio. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.